Skip to content

Farzan Clinical Research and Sanofi-Aventis will launch OPTIC registry in Iran.

Farzan Clinical Research and Sanofi-Aventis will launch OPTIC registry in Iran. They have signed a contract and will soon begin the registry in 5 major Iranian hospitals.

The Outcomes in Patients with TIA and Cerebrovascular disease (OPTIC) registry with the registration number of CLOPI_R_01789, recruits patients for secondary prevention of stroke.

Five clinical sites are located in Tehran and Mashhad, including Hazrat-e-Rasul Hospital, Sina Hospital, Shariati Hospital, Loghman Hospital and Firuzgar Hospital. Patients would be followed for a period of 2 years.

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world’s fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. It is the world’s largest producer of vaccines through its subsidiary Sanofi Pasteur). With more than 110,000 employees in a hundred countries, Sanofi has a strong presence worldwide.

Farzan Clinical Research is the first Iranian Contract Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Science, Research & Technology Institute , Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offering Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Our focus is on innovative solutions that reduce cost and time for our customers.

Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) – Islamic Republic of Iran.

The most visited news

Beginning to implement the plan to use large linguistic models (LLMs) for screening and patient selection in clinical trials (RCTs).

New version of Farzan Clinical Research English website

The multimedia and online training content of “Every House is a Health Centre”, including 22 training courses, was presented.

The Fitasa application was approved by the Ministry of Health and was introduced to medical universities for use.

The smart smoking cessation program (Doodbas) was included in the guideline for Tehran Municipality’s Anti-Tobacco Week.

Approval of Farzan Institute as a knowledge-based ‘export’ company by the Vice President for Science and Technology.

The release of 5 mobile applications by Farzan Institute at App Store in the last month.

The qualification of the Farzan Institute for Health Education has been approved by the Iranian Program and Budget Organisation.

Launch of the new version of the “Hooma: Smart Health Care” system for registration and management of health information

Attendance of Farzan Institute of Science, Research and Technology at the First International Digital Health Event (THL)